Have you been affected by a pharmaceutical injury? We'll give you the representation you need today!
Have you or a loved one experienced excessive internal bleeding after taking Xarelto?
If so, you may be eligible to file a lawsuit against Xarelto, makers of the popular blood-thinning drug.
Patients who took Xarelto are suing Bayer and Janssen Pharmaceutical for failing to warn them of dangerous side effects such as hemorrhaging and internal bleeding. Not only are these side effects potentially fatal but there is no treatment for the uncontrollable bleeding that can result from the use of Xarelto.
Our pharmaceutical lawyers are currently accepting claims from those inflicted with unexpected Xarelto side effects. Time is running out to file your Xarelto lawsuit claim. Fill out the free case evaluation form or call us today!
What is Xarelto?
Xarelto, sometimes known by the generic name rivaroxaban, is an oral anticoagulant manufactured by Bayer AG and marketed by Janssen Pharmaceutica, a subsidiary of Johnson & Johnson.
The drug is a blood thinner that prevents the formation of blood clots in at-risk patients. It was approved by the U.S. Food and Drug Administration in 2011 for treatment of deep vein thrombosis (DVT), which can occur after hip or knee replacement surgeries. It is also used to lower the risk of stroke caused by blood clots in people with atrial fibrillation.
Xarelto has become a profitable drug for Bayer and Johnson & Johnson. In the first quarter of 2016, Xarelto brought in $567 million. An increase of 28.6% from the previous year.
Background of Xarelto Lawsuits
Due to their nature, all blood thinners carry a risk of internal bleeding. Yet Xarelto may carry a higher risk of dangerous internal bleeding than Bayer and Janssen Pharmaceutica originally stated.
As a result, victims of internal bleeding are suing the companies behind Xarelto for negligence and failure to warn the public of potentially deadly side effects. The first lawsuits against Bayer and Johnson & Johnson were filed in 2014 after patients began suffering from uncontrolled bleeding.
One of the first plaintiffs was Virginia Stuntebeck. She was hospitalized in 2013 for severe gastrointestinal bleeding after taking the drug. Her complaint files in the Philadelphia Court of Common Pleas argues that the manufacturers and distributors knew or should have known about irreversible bleeding and never properly advised customers about the risks.
Since 2013, thousands of people have come forward to hold these pharmaceutical giants responsible for selling a potentially dangerous drug.
Why You Should Let Us Handle Your Lawsuit
We have the skills and experience needed to take on large drug companies. Our firm works hard to ensure our clients see the results they deserve.
But our relationship with clients doesn’t just end there. We guide you through the legal process to make sure you feel informed and supported the whole way.
We also work on a 100% contingency basis. That means we don’t get paid unless you win.
We're Here to Make it Easy for You
1 - Contact UsCall the number at the top of the screen, or simply fill out the form at the top of the page.
2 - We'll Evaluate Your Case For FreeNo obligation required. We review the details of your case, and let you know if you qualify for compensation and discuss any questions or concerns you have
3 - We’ll Go to Bat for YouOur drug injury lawyers have experience taking on large pharmaceutical companies and will fight for the compensation you deserve.
Free Case Evaluation
Xarelto Bleeding Warnings Didn’t Go Far Enough
The companies behind Xarelto argue that they warned Xarelto users of the risks. A Johnson & Johnson spokesman told The Wall Street Journal: “The risk of bleeding, a known side effect for all blood thinners, is clearly highlighted in the warnings and precautions of the Xarelto prescribing information.”
Plaintiffs contend that while the medication guide did mention the risk of bleeding, the warning did not go far enough. Hundreds of people have died from bleeding while taking Xarelto. The current Xarelto prescribing information guide does include a stronger warning and notes that a reversal of anticoagulant effect was not available.
History of Xarelto Deception
After it was first approved by the FDA, Xarelto was aggressively marketed as a safer and more convenient alternative to the decades-old warfarin. Warfarin requires patients to undergo frequent blood tests and maintain a strict diet. Xarelto continues to promote the fact that there are no known dietary restrictions and no need for regular blood monitoring.
That may not be the case.
A 2015 study conducted by France’s National Health Insurance Strategy and Research Department found that the risks of bleeding for Xarelto and warfarin are similar. However, unlike warfarin, there is currently no reversal agent to stop uncontrolled bleeding in Xarelto users. The authors recommended physicians exercise caution when administering drugs like Xarelto.
Although there is not enough evidence to suggest Xarelto users seek routine blood tests, plaintiffs in Xarelto lawsuits argue that regular blood tests could have prevented severe bleeding.
But the most alarming evidence against Xarelto is an accusation that claims Bayer and Johnson & Johnson misled The New England Journal of Medicine to protect its lucrative blood thinner. Critical laboratory data was left out of a study used by the FDA to approve the drug. Although the original researchers concluded the omission did not affect the findings, some in the medical community believe otherwise.
Future of Xarelto Lawsuits
In late 2015, more than 4,500 Xarelto lawsuits were consolidated under multidistrict litigation to help speed up the process. Even though these cases will not see trial until early 2017, plaintiffs are confident in their suits against the makers of Xarelto.
The Xarelto lawsuits mimic what happened with another blood thinner called Pradaxa. The German drug maker Boehringer Ingelheim paid $650 million in settlements related to a failure to warn of serious and sometimes fatal internal bleeding that couldn’t be easily reversed.
Pradaxa, yet another blood thinner trying to replace warfarin, was introduced just a year before Xarelto.
Why You Should File a Xarelto Lawsuit
Patients who suffered from internal bleeding after taking the popular blood thinner are victims of unexpected side effects and deserve compensation. Burdensome medical bills from emergency visits and ongoing care are not unusual. Stress associated with a potentially lethal medical condition can also be taxing.
In the event of a wrongful death, the emotional and financial burden of burying a loved one who died from bleeding caused by Xarelto should not fall on the family.
Lawsuits help ensure Bayer and Jannsen Pharmaceutica are held accountable for their negligence and failure to warn the public. Although monetary damages cannot erase the pain and emotional distress of victims, it does work toward ensuring pharmaceutical companies are held accountable for deceptive business practices.
File a Xarelto Lawsuit Today
If you or a loved one have suffered severe internal bleeding as a result of Xarelto, you may be entitled to compensation for your injuries. Contact our firm today via the web form or by phone to receive a free case evaluation. Our Xarelto attorneys are waiting to help you.
Macaroni and cheese is not just a favorite childhood snack but it is also considered one of the best low-cost meals for college students and comfort foods for adults. Now, a recent test of 30 cheese products shows that mac and cheese may contain high concentrations of...read more
The use of mesh in hernia repairs is leaving many patients in chronic pain, according to surgeons interviewed by the BBC’s Victoria Derbyshire program. Mesh implants are the recommended method for treating hernias by NHS England, which is part of the...read more
The first two claims related to the NFL’s settlement with thousands of former players over concussion risks were finally approved for a total of $9 million in benefits. According to the Associated Press, the U.S. District Court for the Eastern District of...read more